Sobel Alan D. bought CTSO
September 15, 2026 · Form 4 insider transaction
Sobel Alan D. bought 100 shares of Cytosorbents Corporation at $6.01 per share, a transaction worth $601.00. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
These transactions reported on this Form 4 reflect open market purchases made by the Reporting Person.; Includes (i) the following restricted stock units ("RSUs") that will be settled into Common Stock upon vesting upon a "Change in Control" of CytoSorbents Corporation (the "Issuer"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 165 RSUs granted on March 15, 2018, (b) 300 RSUs granted on February 24, 2017, (c) 250 RSUs granted on June 7, 2016, and (d) 2,750 RSUs granted on April 8, 2015 and (ii) 6,422 shares of Common Stock owned directly by the Reporting Person.; Reflects the 1-for-20 reverse stock split effected by the Issuer on September 8, 2026.